Gerresheimer AGGRRMF 66 Market Cap is $1,019 Mil as of Jun. 27, 2026. GuruFocus rates GRRMF with a GF Score™ of 66/100 and a GF Value™ of $121.69 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Gerresheimer AG ranks better than 80.25% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Gerresheimer AG's share price for the quarter that ended in Aug. 2025 was $51.41. Gerresheimer AG's Shares Outstanding (EOP) for the quarter that ended in Aug. 2025 was 35 Mil. Therefore, Gerresheimer AG's market cap for the quarter that ended in Aug. 2025 was $1,776 Mil.
Gerresheimer AG's quarterly market cap
declined
from Feb. 2025 ($2,847 Mil) to May. 2025 ($2,549 Mil) and
declined
from May. 2025 ($2,549 Mil) to Aug. 2025 ($1,776 Mil).
Gerresheimer AG's annual market cap
increased
from Nov. 2022 ($1,947 Mil) to Nov. 2023 ($3,143 Mil) but then
declined
from Nov. 2023 ($3,143 Mil) to Nov. 2024 ($3,119 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Gerresheimer AG's Enterprise Value for Today is $3,308 Mil.
Gerresheimer AG (OTCPK:GRRMF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Gerresheimer AG Market Cap Related Terms
Gerresheimer AG Market Cap Historical Data
* Premium members only.
The historical data trend for Gerresheimer AG's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's Market Cap distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Gerresheimer AG's Market Cap for the fiscal year that ended in Nov. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gerresheimer AG (GRRMF) has a Market Cap of $1,019 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Gerresheimer AG and its competitors. According to the industry distribution chart, Gerresheimer AG ranks #171 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 19.7%.
Is Gerresheimer AG's Market Cap too high?
Gerresheimer AG's current Market Cap is $1,019 Mil. The Medical Devices & Instruments industry median Market Cap is 121.29. Gerresheimer AG's value of $1,019 Mil is 740.1% above this industry median. Based on the distribution chart, Gerresheimer AG ranks #171 out of 866 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Gerresheimer AG has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Gerresheimer AG ranks #171 out of 866 companies for Market Cap. This places Gerresheimer AG in the top 20% of its industry — outperforming the majority of peers. The industry median Market Cap is 121.29. Gerresheimer AG's value of $1,019 Mil is 740.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.29, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gerresheimer AG's current Market Cap of $1,019 Mil is 740.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Gerresheimer AG and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gerresheimer AG's current Market Cap is $1,019 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (GRRMF) is currently considered Possible Value Trap. The stock's GF Value™ is $121.69, compared to a current price of $32.10 — trading 73.6% below its estimated fair value. The current Market Cap is $1,019 Mil and 740.1% above the Medical Devices & Instruments industry median of 121.29. Gerresheimer AG's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Gerresheimer AG (GRRMF), the current Market Cap is $1,019 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gerresheimer AG (GRRMF) Overvalued in 2026?
Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued.
The current stock price of $32.10 is trading 73.6% below its estimated GF Value™ of $121.69.
GuruFocus considers Gerresheimer AG to be Possible Value Trap.
Key valuation signals for GRRMF:
Market Cap: $1,019 Mil
GF Value™: $121.69 vs. price of $32.10 (73.6% below fair value)
Industry Position: 740.1% above the Medical Devices & Instruments median (#171 of 866)
No single metric tells the full story. See the GRRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
66GF Score
Get the complete analysis for GRRMF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRRMF has been successfully added to your 
